Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2007
10/31/2007CN100345965C siRNA capable of inhibiting foot and mouth disease virus replication and infection and its preparation method
10/31/2007CN100345592C Mono and disaccharide derivatives
10/31/2007CN100345547C Method of treating prostatic disease using delayed and/or sustained release vitamin D formulations
10/30/2007US7288646 USPA2 nucleic acid of Moraxella catarrhalis
10/30/2007US7288638 Fully human antibodies against human 4-1BB
10/30/2007US7288621 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
10/30/2007US7288390 Anti-dual integrin antibodies, compositions, methods and uses
10/30/2007US7288375 Introducing one or more mutations into a template double-stranded polynucleotide via hybridization, replication and amplification of random genomic double stranded and heterozygous oligonucleotides sequences; genomics and directed evolution
10/30/2007US7288271 Chlorogenic acid and an analog thereof for immune system stimulation
10/30/2007US7288261 Administering to a mammal, an immunogenically effective amount of an Mtb immunogenic protein vaccine
10/30/2007US7288260 Using botulinun toxin to treat pain for sustained release
10/30/2007US7288259 Administering botulinum toxin to the patient, wherein excess levels of glandular secretion result in the conditions which are selected from seborrheic dermatitis, rhinophyma, seborrhea, seborrheic blepharitis and sebaceous cysts, whereby the excess levels of glandular secretions is reduced
10/30/2007US7288258 Polyepitopic protein fragments of the E6 and E7 proteins of HPV, their production and their use particularly in vaccination
10/30/2007US7288257 Using 3,3',5'-triiodothyronine concentration for detecting fibromyalgia, autoimmune, coronary artery, cancer and alzheimer's diseases
10/30/2007US7288256 T cell epitopes of the major allergens from dermatophagoides (house dust mite)
10/30/2007US7288255 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells
10/30/2007US7288254 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
10/30/2007US7288253 Antibodies directed to parathyroid hormone (PTH) and uses thereof
10/30/2007US7288252 Administering antigen , or antagonist antibody; binding; antiproliferative agents; controlling cell differentiation
10/30/2007US7288251 Antibodies to CD40
10/30/2007US7288250 Monoclonal antibodies against HMGB1
10/30/2007US7288249 Antibodies for cancer therapy and diagnosis
10/30/2007US7288248 Antibodies against cancer antigen TMEFF2 and uses thereof
10/30/2007US7288247 Binding antibody to epitopes
10/30/2007CA2272356C Soluble polypeptides
10/30/2007CA2220012C Methods for modulating t cell survival by modulating bcl-xl protein level
10/30/2007CA2145397C Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
10/30/2007CA2142007C Immunomodulatory peptides
10/30/2007CA2105101C The use of the il-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections
10/30/2007CA1341560C Recombinant dna-derived bordetella toxin subunit analogs
10/25/2007WO2007121233A1 Methods of treating autoimmune diseases
10/25/2007WO2007121194A1 Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
10/25/2007WO2007121193A1 Growth regulatable recombinant bcg immunogenic compositions
10/25/2007WO2007121184A2 Compounds and methods for diagnosis and treatment of leishmaniasis
10/25/2007WO2007120860A2 Nanoemulsion vaccines
10/25/2007WO2007120828A1 Use of il-i antibodies for treating ophthalmic disorders
10/25/2007WO2007120823A2 Uses and compositions for treatment of psoriasis
10/25/2007WO2007120767A2 Agonist erythropoietin receptor antibodies
10/25/2007WO2007120720A2 Uses and compositions for treatment of crohn's disease
10/25/2007WO2007120693A2 Targeted binding agents directed to upar and uses thereof
10/25/2007WO2007120673A2 Immunogenic wt-1 peptides and methods of use thereof
10/25/2007WO2007120658A1 Melanoma biomarker and methods of uses
10/25/2007WO2007120656A2 Uses and compositions for treatment of rheumatoid arthritis
10/25/2007WO2007120651A2 Uses and compositions for treatment of juvenile rheumatoid arthritis
10/25/2007WO2007120626A2 Uses and compositions for treatment of ankylosing spondylitis
10/25/2007WO2007120362A2 Adipogenic adenoviruses as a biomarker for disease
10/25/2007WO2007120170A2 Compositions and methods for treating gram positive bacterial infection in a mammalian subject
10/25/2007WO2007119859A1 Protein complex and process for production thereof
10/25/2007WO2007119796A1 Mutant polypeptide having effector function
10/25/2007WO2007119623A1 Novel use of g-protein-conjugated receptor and ligand thereof
10/25/2007WO2007119515A1 Novel tumor antigen peptides
10/25/2007WO2007119447A1 Therapeutic agent for rheumatoid arthritis
10/25/2007WO2007119279A1 Dna vaccine for koi herpes virus (khv) disease
10/25/2007WO2007119011A2 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family
10/25/2007WO2007118987A1 Concentrate of chikungunya-specific immunoglobulins as medicine
10/25/2007WO2007118986A2 Concentrate of immunoglobulins and f(ab)'2 and/or fab fragments specific of an arbovirus as medicine
10/25/2007WO2007118979A1 Type 5 and type 8 capsular polysaccharides of superproducing staphylococcus aureus strains
10/25/2007WO2007118660A2 Her-2/neu multi-peptide vaccine
10/25/2007WO2007118431A1 Use of trap protein as active ingredient for manufacturing a medicament for the treatment of staphylococcus aureus infection
10/25/2007WO2007118284A1 Influenza virus vaccine
10/25/2007WO2007095320A3 Hpv antigens, vaccine compositions, and related methods
10/25/2007WO2007086994A9 Single chain fragment of monoclonal antibody 9b9 and uses thereof
10/25/2007WO2007081365A3 Multiple antigenic agents and methods for using the same
10/25/2007WO2007062063A3 Recombinant viral compositions and uses thereof
10/25/2007WO2007055916A3 Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof
10/25/2007WO2007052165A3 A lentiviral vector-based vaccine
10/25/2007WO2007047981A3 Tumor-targeted nanodelivery systems to improve early mri detection of cancer
10/25/2007WO2007018482A3 Polypeptides for inducing a protective immune response against staphylococcus aureus
10/25/2007WO2007011968A3 Beta-glucuronide-linker drug conjugates
10/25/2007WO2007001459A3 Compositions and methods for modulating lymphocyte activity
10/25/2007WO2006133145A3 Tat-007 and methods of assessing and treating cancer
10/25/2007WO2006076410A3 Li-key/antigenic epitope hybrid peptide vaccines
10/25/2007WO2006076254A3 Method of treating or preventing respiratory microbial infection of respiratory tissue
10/25/2007WO2002099074A3 Slc7s as modifiers of the p53 pathway and methods of use
10/25/2007US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes)
10/25/2007US20070249734 Method, Composition and Kit for Detecting Phosphatidylserine (Ps) on Cell Membranes
10/25/2007US20070249565 Class of Gamma Delta T Cells Activators and Use Thereof
10/25/2007US20070249529 Compositions Comprising Polypeptides
10/25/2007US20070249033 Methods of terminal sterilization of biological products
10/25/2007US20070249020 Cytokine zcytor17 ligand polypeptides and polynucleotides
10/25/2007US20070248972 Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
10/25/2007US20070248686 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same
10/25/2007US20070248679 Vaccine
10/25/2007US20070248676 Use of nitric oxide adducts
10/25/2007US20070248646 Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage
10/25/2007US20070248628 Immunogens in cancer stem cells
10/25/2007US20070248627 Gene Therapy for Tumors Using Minus-Strand Rna Viral Vectors Encoding Immunostimulatory Cytokines
10/25/2007US20070248626 Recombinant toxin fragments
10/25/2007US20070248625 For preventing or treating Orthopoxvirus infection that induces a protective or therapeutic immune response
10/25/2007US20070248624 (1,10B-Dihydro-2-(Aminocarbonyl-Phenyl)-5h-Pyrazolo[1,5-C][1,3]Benzoxazin-5-Yl)Phenyl Methanone Derivatives as Hiv Viral Replication Inhibitors
10/25/2007US20070248623 Gene Construction, Vector and Dna Vaccine for the Vaccination of Aquatic Animals
10/25/2007US20070248622 Attenuated francisella bacteria
10/25/2007US20070248618 Tat-Based vaccine Compositions and Methods of Making and Using Same
10/25/2007US20070248617 Medical Uses of Carrier Conjugates of Non-Human Tnf -Peptides
10/25/2007US20070248616 Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase
10/25/2007US20070248615 T helper cell epitopes
10/25/2007US20070248614 Vaccination
10/25/2007US20070248613 Human Antibodies Interacting with Hiv Gp41
10/25/2007US20070248612 Isolated Plasma And Method For Hyperimmunisation And Plasma Collection
10/25/2007US20070248611 Methods wanted for treating unwanted weight loss or eating disorders by administering a trkb agonist
1 ... 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 ... 1823